Harm-to-Benefit Ratio of Fecal Immunochemical Test-Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations.
Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, Katsara MA, de Jonge L, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I, Meester RGS.
Toes-Zoutendijk E, et al. Among authors: de jonge l.
Clin Gastroenterol Hepatol. 2024 Oct 11:S1542-3565(24)00878-4. doi: 10.1016/j.cgh.2024.08.041. Online ahead of print.
Clin Gastroenterol Hepatol. 2024.
PMID: 39395573
Free article.